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Abstract
The cytoskeletons of Toxoplasma gondii and related apicomplexan parasites are highly polarized, with apical and basal
regions comprised of distinct protein complexes. Components of these complexes are known to play important roles in
parasite shape, cell division, and host cell invasion. During an effort to discover the biologically relevant target of a small-
molecule inhibitor of T. gondii invasion (Conoidin A), we discovered a novel cytoskeletal protein that we named TgCBAP
(Conserved Basal Apical Peripheral protein). Orthologs of TgCBAP are only found in the genomes of other apicomplexans;
they contain no identifiable domains or motifs and their function(s) is unknown. As a first step toward elucidating the
function of this highly conserved family of proteins, we disrupted the TgCBAP gene by double homologous recombination.
Parasites lacking TgCBAP are as sensitive to the effects of Conoidin A as wild-type parasites, demonstrating that TgCBAP is
not the biologically relevant target of Conoidin A. However, DTgCBAP parasites are significantly shorter than wild-type
parasites and have a growth defect in culture. Furthermore, TgCBAP has an unusual subcellular localization, forming small
rings at the apical and basal ends of the parasite and localizing to punctate, ring-like structures around the parasite
periphery. These data identify a new marker of the apical and basal subcompartments of T. gondii, reveal a potentially novel
compartment along the parasite periphery, and identify TgCBAP as a determinant of parasite size that is required for a
maximally efficient lytic cycle.
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Introduction
Toxoplasma gondii is a member of the Phylum Apicomplexa,
which includes many organisms pathogenic to humans (e.g.,
Plasmodium, Cryptosporidium and Babesia spp.), domestic animals and
wildlife (e.g., Eimeria, Sarcocystis, and Theileria spp.). Infections by
apicomplexan parasites can cause severe disease in the host, often
resulting in significant morbidity, mortality, and socio-economic
burden. Knowledge of the basic biology of these evolutionarily
divergent parasites is a prerequisite for designing effective
diagnostics and therapeutics. T. gondii is considered a model
apicomplexan parasite due to the relative ease with which it can be
propagated and the availability of powerful molecular genetic tools
to study conserved features and mechanisms of apicomplexan
biology [1–6].
Apicomplexan parasites share a unique cytoskeletal and
pellicular architecture [7]. They are bounded by an outer plasma
membrane supported by flattened, plate-like alveoli termed the
inner membrane complex (IMC) [8] [9]; together, the plasma
membrane and IMC comprise the pellicle. The subpellicular
network is a meshwork of intermediate-filament like proteins
located on the interior surface of the IMC [10–12]. This structure
acts as a membrane skeleton providing mechanical strength to the
pellicle [13]. Adjacent to the cytoplasmic face of the T. gondii
subpellicular network, 22 highly stable microtubules spiral
posteriorly from an apical polar ring, terminating approximately
two-thirds down the length of the parasite [14]. At the most apical
end of the pellicle, T. gondii and many other apicomplexans are
equipped with a dynamic spring-like structure called the conoid.
The conoid is composed of a novel polymeric form of tubulin and
assumes the shape of a truncated cone that extends and retracts as
the parasites glide along surfaces and during invasion of host cells
[15]. The function of the conoid is currently unknown.
In the course of developing a set of chemical tools to study T.
gondii motility and invasion, a small molecule referred to as
Conoidin A [2,3-bis(bromomethyl)quinoxaline 1,4-dioxide] was
found to be an inhibitor of Ca2+-induced conoid extension and
host cell invasion [16]. A subsequent report identified peroxir-
edoxin II (TgPRXII) and a protein we refer to here as TgCBAP
(for Conserved Basal Apical Peripheral protein)
(TgME49_267500) as Conoidin A-binding proteins in T. gondii
[17]. Conoidin A was shown to inhibit recombinant TgPRXII
through covalent modification of the peroxidatic cysteine, but
DTgPRXII knockout parasites did not show reduced sensitivity to
Conoidin A, arguing that TgPRXII is not the biologically relevant
target of the compound [17].
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We report here the generation of a TgCBAP knockout parasite
(DTgCBAP), which also showed no change in sensitivity to
Conoidin A. However, DTgCBAP parasites have an altered
morphology compared to wild-type parasites and show a fitness
defect in culture. TgCBAP has an extraction profile that suggests a
cytoskeletal association, and an unusual localization within the
parasite, forming both apical and basal ring structures and distinct
punctate spots along the parasite periphery. TgCBAP is therefore
a previously unrecognized pellicular protein of apicomplexan
parasites that plays a role in regulating parasite size and fitness.
Materials and Methods
Culture of parasites
T. gondii tachyzoites (ku80::hxgprt strain [18] kindly provided by
Dr. Vern Carruthers, University of Michigan) and transgenic
derivatives were used for all experiments unless otherwise
indicated. Parasites were serially passaged in confluent human
foreskin fibroblasts (HFFs; ATCC CRL-1634) (37uC, 5% CO2,
constant humidity) in Dulbecco’s Modified Eagle’s Medium
(DMEM) containing 1% (v/v) fetal bovine serum (FBS), 10 mg/
Figure 1. Generation of a DTgCBAP knockout parasite line. (A) The TgCBAP gene was ablated in ku80::hxgprt parasites using a construct
encoding the ble gene, which encodes for resistance to the drug phleomycin [21], flanked by genomic sequences homologous to the 59 and 39
regions of the TgCBAP open reading frame. (B) Rabbit TgCBAP antiserum reacts with both the recombinant NHis-TgCBAP used as the antigen to
generate the antiserum and with a single protein in T. gondii lysates with the predicted molecular weight of TgCBAP (25.7 kDa). (C)
Immunofluorescence analysis of T. gondii parental (ku80::hxgprt), knockout (DTgCBAP), and cosmid complemented (DTgCBAP::TOXOF64) parasites
labeled with anti-IMC1 (green) and blot affinity purified anti-TgCBAP (red) antibodies. Scale bar = 5 mm. (D) Lysates of ku80::hxgprt, DTgCBAP, and
DTgCBAP::TOXOF64 parasite lines were analyzed by Western blot using antisera against TgCBAP and TgACT1 (loading control).
doi:10.1371/journal.pone.0098492.g001
Figure 2. DTgCBAP knockout parasites display unaltered
sensitivity to Conoidin A. Ionomycin-induced conoid extension
assays using DTgCBAP, parental (ku80::hxgprt), and RH strain parasites.
Parasites were pretreated for 15 min with either 5 mM or 50 mM
Conoidin A (or an equivalent amount of DMSO), followed by a 5 min
incubation in the presence of 10 mM ionomycin. Ionomycin-induced
conoid extension is blocked to the same extent by Conoidin A in the
three parasite lines. The data shown represent the mean values from 3
independent experiments (+/2 SEM).
doi:10.1371/journal.pone.0098492.g002
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ml streptomycin sulfate, 10 units/ml penicillin G, and 10 mM
HEPES buffer, pH 7.2 [4].
Production of TgCBAP rabbit antiserum and blot affinity
purification
The open reading frame encoding TgCBAP was amplified from
cDNA using primers designed to add six tandem histidine residues
(6X His-tag) to the N-terminus of TgCBAP. The N-terminal 6X
His-TgCBAP fusion amplicon was ligated into pET28a(+)
(Novagen, EMD Millipore, Darmstadt, Germany). The resulting
construct (pET28a-NHis-TgCBAP) was used to transform E. coli
BL21(DE3)RIPL cells (Agilent Technologies, Santa Clara, CA).
Production of NHis-TgCBAP was induced in mid-log phase
cultures by the addition of 0.4 mM isopropyl b-D-1-thiogalacto-
pyranoside (IPTG) and continued incubation at 37uC for 4 h.
Bacterial cells were harvested by centrifugation (4,000xg) for
10 min at 4uC. The resulting cell pellets were lysed using Bacterial
Protein Extraction Reagent (B-PER; Pierce, Rockford, IL)
according to the manufacturer’s instructions. Lysates were
centrifuged at 21,000xg for 30 min at 4uC to separate inclusion
bodies containing NHis-TgCBAP from soluble protein. Inclusion
bodies were solubilized by boiling in 1X Laemmli sample buffer
(50 mM Tris-HCl, pH 6.8, 2% (w/v) SDS, 10% (v/v) glycerol,
1% (v/v) b-mercaptoethanol, 12.5 mM EDTA, 0.02% (w/v)
bromophenol blue) and resolved using 10% polyacrylamide-SDS
gels. Gels were stained with Colloidal Coomassie Blue G-250. Gel
slices containing a total of ,500 mg of NHis-TgCBAP protein
were submitted to Cocalico Biologicals, Inc. (Reamstown, PA) for
Figure 3. TgCBAP localizes to least three distinct subcompart-
ments in T. gondii parasites. Immunofluorescence assays of T. gondii
ku80::hxgprt parasites expressing C-terminal endogenously tagged
TgCBAP-YFP or TgCBAP-3xmyc fusion proteins. (A) Three representative
examples of live intracellular parasites expressing TgCBAP-YFP. The
parasite in the left panel has been outlined in white for reference. The
right panel shows two parasites that have just emerged from a mother
cell. TgCBAP localizes to rings at the apical (‘‘A’’, blue arrows) and basal
(‘‘B’’, red arrows) ends of the parasites as well as punctate structures
along the periphery (‘‘P’’, white arrows). (B) Paraformaldehyde-fixed
extracellular parasites expressing TgCBAP-3xmyc with anti-myc (red)
and anti-IMC1 (green) antibodies show an identical staining pattern as
TgCBAP-YFP. (C) Three representative deconvolved maximum intensity
projections of TgCBAP-3xmyc parasites dual labeled for myc and IMC1
as in panel B. The peripheral punctate structures containing TgCBAP
vary in number and location. A similar punctate labeling along the
periphery was seen after fixation with 0.2% (v/v) glutaraldehyde (data
not shown). Scale bars = 5 mm.
doi:10.1371/journal.pone.0098492.g003
Figure 4. TgCBAP localizes to forming daughter parasites
during endodiogeny. Immunofluorescence localization of endoge-
nously tagged TgCBAP-3xmyc within T. gondii ku80::hxgprt parasites
undergoing endodiogeny. Parasites were stained with anti-IMC1 (red)
to outline the mother and daughter parasites and anti-myc (green) to
localize TgCBAP-3xmyc; deconvolved maximum intensity projections
are shown. (A,B) A basal ring of TgCBAP staining is evident in both the
mother cell (arrowhead) and forming daughters (arrows). The peripheral
puncta are difficult to resolve on the surface of the forming daughter
cells; however, 3D reconstructions suggest that these may be present as
well (see Movie S1) (C) Peripheral puncta organized in stripes are clearly
evident in mature, emerging daughter cells (arrows), as are the basal
rings (arrowheads). Scale bars = 5 mm.
doi:10.1371/journal.pone.0098492.g004
Figure 5. The detergent extraction profile of TgCBAP suggests
association with the parasite cytoskeleton. Parasites were
extracted with four different detergent-containing buffers (see Meth-
ods), centrifuged at 21,000xg, and analyzed by Western blot using
antibodies against TgCBAP, TgTUB1, TgACT1, and TgIMC1. P, pellet; S,
supernatant.
doi:10.1371/journal.pone.0098492.g005
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antiserum generation in rabbits pre-screened for low pre-bleed
serum reactivity toward Toxoplasma antigens.
Procedures for the blot-affinity purification of the TgCBAP
antibody were adapted from [19] and [20]. E. coli lysates
containing recombinant NHis-TgCBAP were transferred to a
PVDF membrane and blocked in 5% (w/v) nonfat milk in TBS-T
(20 mM Tris pH 7.4, 150 mM NaCl, 0.1% (v/v) Tween) for 1 h.
TgCBAP rabbit antiserum (diluted 1:10 in TBS-T+5% nonfat
milk) was added to the membrane and incubated 18–20 h at 4uC.
The diluted antiserum was removed and a fresh volume of diluted
antiserum was added to the membrane two more times to increase
the total amount of antibody bound. Each volume of diluted
antiserum was checked before and after incubation for reactivity
toward TgCBAP by Western blot using ku80::hxgprt and DTgCBAP
lysates. After the third incubation, the membrane was washed
three times in TBS-T for 15 min, once in PBS for 15 min, and
once in deionized water for 15 min at 23uC. A strip of membrane
containing TgCBAP was excised, cut into small pieces, and placed
into a 1.5 ml microcentrifuge tube. The absorbed TgCBAP
antibody was eluted 3 times by incubation of the membrane pieces
with 200 ml of 0.2 M glycine, pH 2.5 for 3 min. Each elution was
immediately neutralized by addition of 20 ml 1 M Tris, pH 8.0.
Elutions were combined and the antibody solution was concen-
trated to 50 ml using an Amicon Ultra 0.5 ml centrifugal filter
(MWC 10 kDa; Millipore, EMDMillipore, Darmstadt, Germany).
The purified antibody was stored at 4uC.
Generation of the TgCBAP knockout parasite line
(DTgCBAP)
All PCR reactions were performed with Phusion DNA
polymerase (New England Biolabs, Ipswitch, MA). All primers
were synthesized by Sigma-Aldrich (The Woodlands, TX) and
restriction enzymes were sourced from NEB. PCR was performed
on ku80::hxgprt genomic DNA using primers KpnITgCBAP5-F (59-
Figure 6. TgCBAP localization relative to the cytoskeletal
proteins TgMORN1 and TgISP1. (A) TgCBAP-3myc (blue arrow-
heads) localizes to a ring-like structure slightly anterior to TgMORN1
(red arrowheads) at the basal end of extracellular parasites. (B) The
apical TgCBAP ring, labeled here with affinity-purified anti-TgCBAP
(blue arrowheads), localizes slightly posterior to TgISP1 (green
arrowheads). (C) The TgCBAP apical ring (blue arrowheads) is also
located at the anterior edge of the subpellicular microtubules. Parasites
in (A) and (B) were extracted in 0.5 mM deoxycholate; parasites in (C)
were extracted in 10 mM deoxycholate. Labeling of the peripheral
puncta is disrupted by deoxycholate extraction. The parasites in the
merged images have been outlined in white for reference. Scale
bars = 5 mm.
doi:10.1371/journal.pone.0098492.g006
Figure 7. Disruption of TgCBAP does not affect the localization
of TgMORN1 or TgISP1. TgMORN1 and TgISP1 localization in (A)
parental (ku80::hxgprt) and (B) DTgCBAP parasites is indistinguishable.
(C) Disruption of TgCBAP also does not change the rosette-like
organization of parasites within the parasitophorous vacuole. The
parasites in (A) and (B) have been outlined in white in the merged
images for reference. Scale bars = 5 mm.
doi:10.1371/journal.pone.0098492.g007
Figure 8. Parasites lacking TgCBAP are significantly smaller
than parental parasites. Length (L) and width (W) dimensions of T.
gondii parental (ku80::hxgprt), knockout (DTgCBAP), and cosmid-
complemented (DTgCBAP::TOXOF64) parasites were measured from
DIC images of live extracellular parasites adhered to coverslips using BD
Cell-Tak. The greatest dimension along the long and short axes of the
parasite was determined using ImageJ and is shown in mm 6 SEM.
Parasites deficient in TgCBAP are shorter than parental and cosmid-
complemented parasites: length differences were statistically significant
between ku80::hxgprt and DTgCBAP parasites and between DTgCBAP
and DTgCBAP::TOXOF64 parasites, but not between ku80::hxgprt and
DTgCBAP::TOXOF64 parasites (unpaired Student’s t-test; ns = not
significant). Scale bars = 5 mm.
doi:10.1371/journal.pone.0098492.g008
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AAAAGGTACCTGGCTTGGAATGAGTGTGAATG-39) and
Hind3TgCBAP5-R (59-GGGGAAGCTTAACTCGTCAACC-
GACAATTGCC-39), and BamHITgCBAP3-F (59-AAAAG-
GATCCGTAGAAGCTCCAAGAGCCGTTG-39) and XbaITg
CBAP3-R (59- GGGGTCTAGATCTCTTGTCAACACGC-
CATGGG-39) to amplify the 59 and 39 flanking regions of
TgCBAP, respectively. To generate the DTgCBAP knockout
plasmid, the 0.95 kb PCR amplicon of the 59 flanking region
was cloned into the KpnI and HindIII sites upstream of the GRA1
promoter and the 0.8 kb amplicon of the 39 flanking region was
cloned into the BamHI and XbaI sites downstream of the SAG1 39
UTR in pGRA1/ble [21]. The plasmid was linearized with KpnI
prior to transfection of ku80::hxgprt parasites. The transfected
parasites were selected with phleomycin as previously described
[21]. Clones lacking TgCBAP were isolated by limiting dilution,
identified by immunofluorescence and verified by Western blot
using TgCBAP rabbit antiserum.
Endogenous locus tagging of TgCBAP with 3xmyc or YFP
T. gondii ku80::hxgprt genomic DNA was used as a template to
amplify a 1.26 kb genomic fragment of the TgCBAP coding region
using primers PacITgCBAPg-F (59-CCCCTTAATTAAGCAGC
TCTTCGCTCGAATGCAGCAAG-39) and AvrIITgCBAPg-R
(59-GGGGCCTAGGCTGGTAGACGGGACTGTAAAGATTT
G-39) or EcoRITgCBAPg-F (59-GGGGGAATTCCTGGTA-
GACGGGACTGTAAAGATTTG-39). The genomic fragments
were cloned into either the PacI and AvrII sites of p3xmyc-dhfr or
the PacI and EcoRI sites of pYFP-hxgprt, fusing the penultimate
TgCBAP codon in-frame with either the 3xmyc or YFP coding
sequence. Plasmids were linearized with BsiWI prior to transfec-
tion of Dku80 parasites [22], kindly provided by Dr. David Bzik,
Dartmouth College. Parasites transfected with pTgCBAP-3xmyc-
dhfr were selected with pyrimethamine as previously described [4].
Clones expressing TgCBAP-3xmyc were isolated by limiting
dilution, then identified by immunofluorescence and verified by
Western blot using a mouse monoclonal anti-Myc antibody (9E10;
Developmental Studies Hybridoma Bank, University of Iowa).
Transient pTgCBAP-YFP-HXGPRT transfectants were identified
by live-cell immunofluorescence.
Complementation of the DTgCBAP parasite line
(DTgCBAP::TOXOF64)
To complement the deletion of TgCBAP, the cosmid TOXOF64
containing the entire TgCBAP locus was electroporated into
DTgCBAP parasites. Transfectants were selected using pyrimeth-
amine as previously described [4]. Complemented parasites
expressing TgCBAP were identified by Western blot using
TgCBAP rabbit antiserum and by immunofluorescence using
blot-affinity purified TgCBAP polyclonal antibody.
Immunofluorescence
Extracellular parasites were attached to glass coverslips using
BD Cell-Tak (BD Bioscience, San Jose CA). All manipulations
were carried out at 23uC. For labeling with blot-affinity purified
anti-TgCBAP antibody, attached parasites were extracted in
0.5 mM sodium deoxycholate in PBS for 5 min, fixed in PBS
containing 4% (v/v) paraformaldehyde for 10 min, and then
blocked in PBS containing 5% (w/v) nonfat milk for 30 min. The
parasites were incubated with blot-affinity purified anti-TgCBAP
diluted 1:200 in PBS+5% nonfat milk for 30 min. Parasites were
similarly labeled with either mouse MAb 45.36 anti-IMC1
(1:2000), rabbit anti-TgMORN1 (1:1000; a generous gift from
Dr. Marc-Jan Gubbels; [23]), or mouse anti-ISP1 (1:2000; a
generous gift from Dr. Peter Bradley; [24]). Parasites labeled with
anti-a-tubulin antibody B-5-1-2 (Sigma-Aldrich, The Woodlands,
TX) were first adhered to BD CellTak-coated coverslips and
extracted in 10 mM deoxycholate in PBS for 30 min, fixed in PBS
containing 4% (v/v) paraformaldehyde for 10 min, blocked with
PBS containing 2% (w/v) bovine serum albumin (BSA), and
labeled with MAb B-5-1-2, diluted 1:1000 in PBS+2% (w/v) BSA.
After incubation with primary antibodies, the samples were
incubated with a 1:1000 dilution of Alexa488- and/or Alexa546-
conjugated secondary antibody (Invitrogen, Carlsbad, CA).
Fluorescently-stained parasites were imaged using a 60X PlanApo
objective on Nikon Eclipse TE300 epifluorescence microscope.
Images were captured using an iXon 885 EMCCD camera (Andor
Technology, Belfast, Ireland) cooled to 270uC and driven by NIS
Elements v. 3.20 software (Nikon Instruments). Final images were
processed by Adobe Photoshop. Deconvolved images were
captured using a Nikon Eclipse Ti2000 microscope with a
PlanApo 60X (1.4 NA) oil immersion objective (Olympus,
Melville, NY), High-Q filter sets (Chroma Technology, Brat-
tleboro,VT) a Z-spacing of 0.26 mm, and a Qimaging ExiBlue
digital camera (Surrey, British Colombia, Canada). Image
deconvolution parameters were set for 40 iterations and
deconvolved using Autoquant X software (MediaCybernetics).
Conoid extension assay
Conoid extension assays were performed as previously de-
scribed [25]. Syringe-released and filtered parasites were pretreat-
ed for 15 min with 5 mM Conoidin A, 50 mM Conoidin A, or an
equivalent amount of DMSO, then incubated for 5 min at 23uC in
Hanks Buffered Salt Solution (HBSS; Invitrogen) containing
10 mM ionomycin (Sigma) or an equivalent volume of DMSO.
Parasites were fixed for 1 h at 23uC in HBSS containing 1% (v/v)
glutaraldehyde, smeared onto a glass slide, and air-dried. 100
parasites were scored as exhibiting either an extended or retracted
conoid by phase contrast microscopy. Conoid extension assays
Figure 9. Growth defect of DTgCBAP knockout parasites is
restored in cosmid-complemented parasites. Equal numbers of T.
gondii parental (ku80::hxgprt), knockout (DTgCBAP), and cosmid-
complemented (DTgCBAP::TOXOF64) parasites were added pairwise to
HFF monolayers and serially passaged. At passage number 1, 2, 4, 8, and
12, immunofluorescence detection of TgCBAP was performed on
extracellular parasites. Each experiment was performed in duplicate and
results shown are the averages of the two biological replicates (+/2
SEM). Parental (ku80::hxgprt; red closed circles) and cosmid-comple-
mented (DTgCBAP::TOXOF64; blue open circles) parasites exhibited a
faster growth than parasites lacking TgCBAP (DTgCBAP; red closed
squares or blue open squares). The difference between parasites
expressing TgCBAP and parasites lacking TgCBAP is significant
(unpaired Student’s t-test, p,0.05) by passage 8.
doi:10.1371/journal.pone.0098492.g009
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were performed three times for total of 300 parasites scored for
each treatment.
Differential detergent extraction of extracellular parasites
Syringe-released, filtered parasites were resuspended at
16108 parasites/ml and extracted for 30 min on ice using the
following detergents: Digitonin (0.015% [v/v] digitonin, 150 mM
NaCl, 1X PBS, pH 7.4); Triton X-100 (1.5% [v/v] Triton X-100,
150 mM NaCl, 1X PBS, pH 7.4); RIPA buffer (1% [v/v] Triton
X-100, 0.5% [w/v] sodium deoxycholate, 0.1% [v/v] SDS,
50 mM Tris, pH 8.0, 150 mM NaCl); or SDS (1% [v/v] SDS,
50 mM Tris, pH 8.0, 150 mM NaCl). Extracts were then
centrifuged (21,000xg) for 30 min at 4uC to separate soluble and
insoluble cellular components. Equivalent amounts of protein from
supernatants and pellets were solubilized by boiling in 1X
Laemmli sample buffer. Samples were separated through 12%
polyacrylamide-SDS gels, transferred to Immobilon-FL mem-
branes (Millipore), blocked with 5% [w/v] nonfat milk, then
probed with anti-TgCBAP rabbit antiserum (1:100), MAb 45-36
(anti-IMC1, 1:1000), MAb B-5-1-2 (anti-a-tubulin, 1:400), and
anti-TgACT1 (anti-actin, 1:10,000; a generous gift from Dr. David
Sibley, Washington University in St. Louis). Membranes were
washed in PBS, incubated for 2 h with secondary antibodies
(IRDye 800 CW-conjugated anti-mouse and IRDye 680 CS-
conjugated anti-rabbit, each at 1:20,000), washed in PBS, and
scanned using an Odyssey Imaging System CLx (LI-COR
Biosciences, Lincoln, NE).
Growth competition assay
After parasite infections produced 60–70% lysis of the HFF
monolayer in their respective flasks, T. gondii ku80::hxgprt,
DTgCBAP, and the cosmid complemented clone (DTgCBAP::-
TOXOF64) were syringe-released and filtered with a 3 mm
Nuclepore syringe filter (Whatman, GE Healthcare). 26105
parasites of each strain were transferred pairwise to a freshly
confluent monolayer of HFF cells in a 25 cm2 flask. Immediately
following complete lysis of the monolayers (ca. 36 h post-infection),
0.3 ml of parasites resuspended in culture supernatant were added
to a new HFF monolayer. Culture medium was replaced 12 h
after each passage. After passages 1, 2, 4, 8, and 12 a sample of
extracellular parasites was removed and the relative number of
TgCBAP(-) and TgCBAP(+) parasites determined by immunoflu-
orescence using blot-affinity purified rabbit polyclonal anti-
TgCBAP antibody and anti-IMC1. All parasites within randomly
selected 60X fields were scored as either positive or negative for
TgCBAP until 200 parasites were counted per replicate, per strain,
for a total of 400 parasites counted per passage #, per experiment.
Morphometric analysis
Parasites resuspended in HBSS supplemented with 10 mM
HEPES, pH 7.2, were adhered to the bottom of 8-well chambered
coverglasses (Nunc, Rochester NY) using BD Cell-Tak. Parasites
were visualized by differential interference contrast (DIC) micros-
copy using a 100X PlanApo objective on Nikon Eclipse TE300
microscope. Images were captured using an iXon 885 EMCCD
camera as described above. The length of both the long and short
axes of 100 parasites per parasite line was determined using
ImageJ v1.48.
Results and Discussion
Identification of TgCBAP
Previous work demonstrated direct binding of the T. gondii
conoid extension inhibitor, Conoidin A, to a triad of proteins with
apparent molecular weights of 25–30 kDa and isoelectric points of
6.5–7 [17]. Two of these three proteins were identified as isoforms
of peroxiredoxin II (TgPRXII) and the third (TgCBAP) was
annotated as a conserved hypothetical protein (GenBank accession
number XM_002368777, ToxoDB ID TGME49_267500).
Homologs of TgCBAP are found only within the genomes of
apicomplexan organisms, most of which contain a single copy of
the gene, and they contain no recognizable functional domains or
motifs that would provide insight into their biological function(s).
Like TgPRXII, TgCBAP contains multiple cysteine residues
which could potentially act as thiol nucleophiles and bind covalently
to Conoidin A. Interestingly, TgCBAP was detected in the conoid-
enriched fraction in a proteomic study of the T. gondii cytoskeleton
[26]. These preliminary results prompted us to test whether
TgCBAP was the biologically relevant target of Conoidin A and
to begin to characterize the function(s) of this novel protein.
Generation of DTgCBAP knockout parasites
If TgCBAP is the relevant target of Conoidin A, then parasites
lacking TgCBAP should show altered sensitivity to the compound.
The genomic locus encoding TgCBAP was therefore ablated by
transfection of a plasmid construct encoding a phleomycin
resistance cassette [21] flanked by 59 and 39 sequences from
upstream and downstream of the TgCBAP coding sequence
(Figure 1A). We generated rabbit anti-TgCBAP antisera, which
detected a single protein of the predicted molecular weight in T.
gondii lysates (Figure 1B), and we used this antibody to screen the
transfected parasite population for DTgCBAP knockouts. After two
rounds of selection, ,30% of the parasite population lacked
TgCBAP by immunofluorescence. Parasites were cloned by
limiting dilution and again screened for loss of TgCBAP
expression by immunofluorescence (compare Figure 1C, top and
middle panels). Western blotting confirmed the ablation of
TgCBAP expression in several parasite clones, one of which
(Figure 1D) was used for all subsequent experiments.
For phenotypic studies, the DTgCBAP parasites were then
complemented by transfection with a 38.6 kb cosmid (TOXOF64)
spanning the entire TgCBAP locus. After one round of selection with
pyrimethamine, parasites were cloned by limiting dilution and
screened for the presence of TgCBAP expression by Western blot
using the TgCBAP antiserum. Expression of TgCBAP in the cosmid-
complemented parasites was confirmed both by immunofluores-
cence andWestern blotting (Figure 1C, lower panels, and Figure 1D).
Parasites lacking TgCBAP show unchanged sensitivity to
Conoidin A
To test the hypothesis that TgCBAP is the biologically relevant
target of Conoidin A, we compared the ability of Conoidin A to
inhibit conoid extension in the DTgCBAP and parental ku80::hxgprt
parasites. RH strain parasites were also included in these assays,
since this was the original strain against which Conoidin A was
shown to have an effect [16]. No statistically significant differences
in the sensitivity of ku80::hxgprt, RH, or DTgCBAP parasites to
Conoidin A were observed in conoid extension assays (Figure 2);
the compound inhibited ionophore-induced conoid extension in
all three parasite lines to an equivalent extent.
TgCBAP therefore does not appear to be required either for
extension of the conoid or for inhibition of conoid extension by
Conoidin A, even though TgCBAP binds directly to Conoidin A
[17], is found in a conoid-enriched cytoskeletal fraction [26] and
localizes to a ring-like structure at the apical end of the parasite
(discussed further below). T. gondii PRXII knockout parasites also
show unchanged sensitivity to Conoidin A. However, T. gondii
expresses four different peroxiredoxins; if these were to serve
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overlapping functions, the disruption of any single T. gondii PRX
gene might not be sufficient to confer resistance to the compound.
We therefore cannot yet rule out a role for peroxiredoxin proteins
in the mechanism of action of Conoidin A [17].
TgCBAP localizes to three distinct subcompartments in T.
gondii and associates with the cytoskeleton
Immunofluorescence with affinity-purified anti-TgCBAP showed
it had an intriguing distribution within the parasite, being found in
both ring-like structures at the apical and basal ends of the parasite
and distinct punctate structures distributed around the parasite
periphery (Figure 1C). To confirm this localization and to generate
tools for dual immunofluorescence and live-cell imaging, we fused
the 39 end of TgCBAP with either YFP or a 3xmyc epitope tag at the
genomic locus in ku80::hxgprt parasites [18]. Both tagged proteins
showed a localization indistinguishable from that seen with the anti-
TgCBAP antibody: small, ring-like structures near the apical and
basal ends of the parasite as well as punctate spots around the
parasite periphery (Figure 3). The clearest pattern in terms of signal-
to-background was obtained by immunofluorescence using the
TgCBAP-3xmyc parasites (Figure 3B and C). The IMC1 signal
extends past the apical TgCBAP ring (Figures 3B and C),
distinguishing the TgCBAP ring from the apical polar ring.
Maximum intensity projections of deconvolved images of
TgCBAP-3xmyc parasites clearly show heterogeneous punctate
spots around the periphery of the parasite (Figure 3C). However, in
many parasites, the spots appear to be organized in rings around the
circumference of the parasite (Figure 3C & Movies S1 & S2).
During endodiogeny, the process by which daughter cells are
produced within a mother cell, the apical and basal TgCBAP rings
are also seen in daughters as they form within the mother cell
(Figures 4A and B and Movie S1). Rings of peripheral spots are
difficult to visualize on the forming daughters, although 3D
reconstructions suggest their presence (Movie S1) and they are
clearly present by the time the daughter parasites emerge from the
mother cell (Figure 4C). The nature of the ring-like compartment(s)
around the parasite periphery is unknown but may in some way
relate to the junctions between the plates of the IMC [7].
The small apical and basal ring structures suggest an association
of TgCBAP with the parasite cytoskeleton, as previously reported
[26]. The results of differential detergent extraction are consistent
with a cytoskeletal association (Figure 5): the extraction profile of
TgCBAP is identical to that of tubulin and IMC1, and different
from that of actin, which is present primarily in a nonpolymerized
form in T. gondii [27].
TgCBAP partially co-localizes with TgMORN1 and TgISP1
To better define the spatial distribution of TgCBAP relative to
previously described cytoskeletal markers, dual label immunofluo-
rescence assays were performed with TgCBAP and the basal marker
TgMORN1 [23], the apical marker TgISP1 [24], or tubulin [15].
The basal TgCBAP ring-like structure is found slightly anterior to
TgMORN1 (Figure 6A), and at the apical end of the parasite, the
TgCBAP ring localizes slightly posterior to TgISP1 (Figure 6B), at
the posterior end of a gap in tubulin staining between the conoid
and subpellicular microtubules (Figure 6C). The gap in tubulin
staining is likely an artifact caused by inaccessibility of the tubulin
epitope in this region of the parasite [15].
The localizations of TgMORN1 and TgISP1 are unaffected
in parasites lacking TgCBAP
Given the proximity of TgCBAP to TgMORN1 and TgISP1,
we investigated whether the localization of these proteins is altered
in the DTgCBAP parasites and found that it was not (Figure 7).
Furthermore, and in contrast to TgMORN1 [28,29], the lack of
TgCBAP had no effect on the organization of parasites within the
parasitophorous vacuole (Figure 7C). A direct functional interac-
tion between TgCBAP and TgMORN1 therefore seems unlikely,
consistent with the fact that TgCBAP was not identified in a
proteomic analysis of the TgMORN1 complex [30].
Effect of TgCBAP depletion on parasite morphology and
growth
Previous work from our laboratory showed that parasites
lacking another cytoskeletal protein (TgPhIL1) that forms rings at
the apical end of the parasite were significantly shorter and
wider than parental parasites [31]. DTgCBAP parasites are
also significantly shorter than wild-type parasites (Figure 8),
but their width remains unchanged. Complementation of
DTgCBAP parasites with cosmid TOXOF64 containing wild-type
TgCBAP restored the morphology to parental dimensions
(Figure 8).
During routine passage, it was apparent that DTgCBAP parasites
required more time to completely lyse host monolayers than the
parental line. Growth competition assays revealed that DTgCBAP
parasites do indeed display a significant growth impairment
compared to both parental ku80::hxgprt and complemented
DTgCBAP::TOXOF64 parasites (Figure 9).
Conclusions
TgCBAP is a novel protein of T. gondii that localizes to three
distinct subcompartments within the parasite and appears to be
associated with the cytoskeleton. The precise nature of the three
subcompartments and the proteins with which TgCBAP interacts
will be the subject of future investigation. Although the lack of
recognizable functional motifs or domains precludes immediate
insight into the function of TgCBAP or its homologs in other
apicomplexan parasites, T. gondii tachyzoites lacking TgCBAP are
smaller than the parasites from which they were derived and show
a growth defect in culture. TgCBAP therefore appears to play an
as yet undefined role in maintaining parasite size, which in turn
may be important for parasite fitness.
Supporting Information
Movie S1 3D reconstruction of TgCBAP localization.
Reconstruction of deconvolved images of extracellular parasites
rendered as a 3D movie. Parasites expressing TgCBAP-3xmyc
were stained for IMC1 (green) and myc (red). Scale bar = 10 mm.
Note the two parasites in the process of endodiogeny in the upper
left quadrant.
(MPG)
Movie S2 3D reconstruction of TgCBAP localization.
Reconstruction of deconvolved images of extracellular parasites
rendered as a 3D movie. Parasites expressing TgCBAP-3xmyc
were stained for IMC1 (green) and myc (red). Scale
bar = 10 mm.
(MPG)
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